Private Health Sector

Medical device maker Poly Medicure Ltd on Wednesday said it will fully acquire Italy-based Citieffe Group at an enterprise value of Rs 324 crore (EUR 31 million). The company has signed a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, the company said in a statement. Citieffe is an Italy-based manufacturer specialising in the orthopaedic trauma and extremities segment with a direct presence in Italy, USA, and Mexico, and distribution across over 25 countries, it added. This acquisition provides Poly Medicure with an entry point into the large global orthopaedics market, particularly in the trauma and extremities segment, which is the fastest growing and most resilient category within orthopaedics, the company said. "This acquisition marks another step in our journey to become a comprehensive healthcare solutions provider. Citieffe's strong R&D capabilities and diverse trauma

Prime Minister Narendra Modi on Tuesday said the future of a healthy world depends on inclusion, integrated vision and collaboration, as he asserted that India's approach offers replicable, scalable and sustainable models to meet health challenges of the Global South. In his video message during the 78th Session of the World Health Assembly in Geneva, he highlighted this year's theme, 'One World for Health' and emphasized that it aligns with India's vision for global health. Modi recalled his address at the 2023 World Health Assembly, where he had spoken about 'One Earth, One Health' and pointed out that the future of a healthy world depends on inclusion, an integrated vision, and collaboration. Emphasizing that inclusion is at the core of India's health reforms, he highlighted Ayushman Bharat, the world's largest health insurance scheme, which covers 580 million people and provides free treatment. The programme was recently expanded to cover all Indians above the age of 70 years.

Private players say lower rates, delayed dues hampering participation in the scheme

The MSG is the highest policy-making and steering institution under the NHM, providing broad policy direction and governance for the health sector

The hospital body PHANA claimed that it took the step due to unresolved payments of approximately Rs 600 crore owed by the state government, pending for the last six months

APH expects online pharmacy distribution margins to grow to 20 per cent in FY25, from 13.6 per cent currently

Occupancy rates are over 60 per cent for the third year in a row

The Budget Session of Parliament will commence on July 22 and subject to exigencies of Government Business, the session may conclude on August 12

Delhi-based group plans to double overall capacity by adding 4,200 beds in four to five years

The projection indicated a rise in capacity building and occupancy, translating into a year-on-year (Y-o-Y) revenue growth to the tune of 12 to 14 per cent in FY24

President of NCDRC, Justice Amreshwar Prasap Sahi, said that some district forums have innovated and ordered insurance cos to clear claims even when hospitalisation was less than 24 hrs

On a sequential basis, the company exhibited a 3.15 per cent increase in revenue along with EBITDA, which grew 21 per cent year-on-year

A local health board in the UK could be recruiting as many as 900 nurses, mostly from Kerala, in the course of next four years to address workforce shortages

Current approach to be based in common parameters, goals and analysis, as opposed to earlier exercises done on the basis of some research or state-specific issues

Hyderabad-based company will use financing to introduce more product categories and expand team

The two new studies also bolster the theory that the Coronavirus pandemic emerged from the wild rather than escaping from a lab in China

Mansukh Mandaviya said that the goal of the Central Government is to work holistically in the health sector with synergy between preventive healthcare and modern medical facilities

Competitive pricing, however, is here to stay, feel analysts and some industry insiders

'Wave 2' vaccine in the works for Covid-19

Only when both sectors take joint actions, can the country brave another onslaught